n(g),n(g')-dimethyl-l-arginine has been researched along with Coronary Stenosis in 9 studies
N,N-dimethylarginine: asymmetric dimethylarginine; do not confuse with N,N'-dimethylarginine
Coronary Stenosis: Narrowing or constriction of a coronary artery.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Previous studies have shown that Asymmetric Dimethyl Arginine (ADMA) is increased significantly during coronary artery diseases (CAD)." | 7.88 | Evaluation of serum Asymmetric Dimethyl Arginine concentrations in coronary artery disease patients without traditional cardiovascular risk factors. ( Ayati, N; Elyasi, S; Ghayour-Mobarhan, M; Mohammadpour, AH; Moohebati, M; Sahebkar, A, 2018) |
| " A total of 83 patients with hypercholesterolemia and angiographically documented mild coronary artery stenosis were randomized to rosuvastatin treatment (20 mg) or atorvastatin treatment (40 mg) once daily for 6 weeks after a 4-week dietary lead-in phase." | 5.19 | Comparision of effects of rosuvastatin versus atorvastatin treatment on plasma levels of asymmetric dimethylarginine in patients with hyperlipidemia having coronary artery disease. ( Akturk, E; Altas, Y; Atas, H; Balta, S; Can, C; Demirkol, S; Erdem, K; Korkmaz, H; Kurtoglu, E; Sincer, I; Yilmaz, M, 2014) |
| "Previous studies have shown that Asymmetric Dimethyl Arginine (ADMA) is increased significantly during coronary artery diseases (CAD)." | 3.88 | Evaluation of serum Asymmetric Dimethyl Arginine concentrations in coronary artery disease patients without traditional cardiovascular risk factors. ( Ayati, N; Elyasi, S; Ghayour-Mobarhan, M; Mohammadpour, AH; Moohebati, M; Sahebkar, A, 2018) |
| "It has been shown that asymmetric dimethylarginine (ADMA), an endogenous competitive antagonist of nitric oxide (NO) synthase, inhibits angiogenesis by reducing the production and bioavailability of NO." | 1.35 | [The effect of plasma asymmetric dimethylarginine (ADMA) level and L-arginine/ADMA ratio on the development of coronary collaterals]. ( Baysal, E; Duru, E; Maden, O; Saşmaz, A; Selçuk, H; Selçuk, MT; Temizhan, A; Ulupinar, H, 2008) |
| "Asymmetric dimethylarginine (ADMA) that is an endogenous inhibitor of NO synthesis may impair the effective coronary collateral vessel development." | 1.35 | Asymmetric dimethylarginine and coronary collateral vessel development. ( Akyel, A; Biberoglu, G; Cengel, A; Hasanoglu, A; Kocaman, SA; Sahinarslan, A; Timurkaynak, T, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ghayour-Mobarhan, M | 1 |
| Ayati, N | 2 |
| Sahebkar, A | 1 |
| Moohebati, M | 1 |
| Elyasi, S | 1 |
| Mohammadpour, AH | 1 |
| Kurtoglu, E | 1 |
| Balta, S | 1 |
| Sincer, I | 1 |
| Altas, Y | 1 |
| Atas, H | 1 |
| Yilmaz, M | 1 |
| Korkmaz, H | 1 |
| Erdem, K | 1 |
| Akturk, E | 1 |
| Demirkol, S | 1 |
| Can, C | 1 |
| Mokhtari, Z | 1 |
| Hosseini, S | 1 |
| Miri, R | 1 |
| Baghestani, AR | 1 |
| Zahedirad, M | 1 |
| Rismanchi, M | 1 |
| Nasrollahzadeh, J | 1 |
| Selçuk, MT | 1 |
| Selçuk, H | 1 |
| Temizhan, A | 1 |
| Maden, O | 1 |
| Ulupinar, H | 1 |
| Baysal, E | 1 |
| Duru, E | 1 |
| Saşmaz, A | 1 |
| Kocaman, SA | 1 |
| Sahinarslan, A | 1 |
| Biberoglu, G | 1 |
| Hasanoglu, A | 1 |
| Akyel, A | 1 |
| Timurkaynak, T | 1 |
| Cengel, A | 1 |
| Celik, T | 2 |
| Celik, M | 2 |
| Iyisoy, A | 2 |
| Işik, E | 1 |
| Sun, T | 1 |
| Huang, Y | 1 |
| Phillips, MI | 1 |
| Luo, X | 1 |
| Zhu, J | 1 |
| Shi, H | 1 |
| Li, J | 1 |
| Ari, H | 1 |
| Ari, S | 1 |
| Erdoğan, E | 1 |
| Tiryakioğlu, O | 1 |
| Ustündağ, Y | 1 |
| Huysal, K | 1 |
| Koca, V | 1 |
| Bozat, T | 1 |
| Yilmaz, MI | 1 |
| Yuksel, UC | 1 |
| Yaman, H | 1 |
1 trial available for n(g),n(g')-dimethyl-l-arginine and Coronary Stenosis
| Article | Year |
|---|---|
Comparision of effects of rosuvastatin versus atorvastatin treatment on plasma levels of asymmetric dimethylarginine in patients with hyperlipidemia having coronary artery disease.
Topics: Arginine; Atorvastatin; Biomarkers; Coronary Angiography; Coronary Stenosis; Down-Regulation; Female | 2014 |
8 other studies available for n(g),n(g')-dimethyl-l-arginine and Coronary Stenosis
| Article | Year |
|---|---|
Evaluation of serum Asymmetric Dimethyl Arginine concentrations in coronary artery disease patients without traditional cardiovascular risk factors.
Topics: Arginine; Biomarkers; Case-Control Studies; Coronary Artery Disease; Coronary Stenosis; Female; Huma | 2018 |
Relationship between Dietary Approaches to Stop Hypertension score and Alternative Healthy Eating Index score with plasma asymmetrical dimethylarginine levels in patients referring for coronary angiography.
Topics: Aged; Arginine; Coronary Angiography; Coronary Disease; Coronary Stenosis; Cross-Sectional Studies; | 2015 |
[The effect of plasma asymmetric dimethylarginine (ADMA) level and L-arginine/ADMA ratio on the development of coronary collaterals].
Topics: Arginine; Chromatography, High Pressure Liquid; Collateral Circulation; Confidence Intervals; Corona | 2008 |
Asymmetric dimethylarginine and coronary collateral vessel development.
Topics: Adult; Aged; Arginine; Biomarkers; Collateral Circulation; Coronary Angiography; Coronary Circulatio | 2008 |
[The effect of plasma asymmetric dimethylarginine (ADMA) level and L-arginine/ADMA ratio on the development of coronary collaterals].
Topics: Arginine; Collateral Circulation; Coronary Stenosis; Humans; Nitric Oxide Synthase | 2008 |
Growth differentiation factor 15 and coronary collateral formation.
Topics: Aged; Analysis of Variance; Arginine; Collateral Circulation; Coronary Angiography; Coronary Artery | 2010 |
A novel predictor of restenosis and adverse cardiac events: asymmetric dimethylarginine.
Topics: Aged; Angioplasty, Balloon, Coronary; Arginine; Biomarkers; C-Reactive Protein; Coronary Angiography | 2010 |
The relationship between L-arginine/ADMA ratio and coronary collateral development in patients with low glomerular filtration rate.
Topics: Adult; Aged; Aged, 80 and over; Arginine; Biomarkers; Chi-Square Distribution; Collateral Circulatio | 2012 |